Background of the Study
Genomic variants, including single nucleotide polymorphisms (SNPs) and insertions/deletions (indels), play a critical role in determining an individual’s phenotype and disease risk. Accurate analysis of these variants is essential for advancing personalized medicine. At Adamawa State University, Mubi, researchers are evaluating AI-based approaches to enhance the analysis of genomic variants. This study leverages advanced artificial intelligence techniques, such as deep learning and neural networks, to improve variant detection and classification (Ibrahim, 2023). By processing high-throughput sequencing data, the AI models can identify subtle genetic variations with greater precision than traditional methods. The system incorporates pre-processing pipelines, variant calling algorithms, and classification models that work in tandem to distinguish between benign and pathogenic variants. Furthermore, the approach integrates external databases and functional annotation tools to provide a comprehensive interpretation of genomic alterations (Chukwu, 2024). The interdisciplinary effort combines expertise from computational biology, genomics, and clinical genetics to ensure that the AI models are both robust and clinically applicable. This innovative approach not only accelerates the analysis process but also reduces the error rate, enabling more accurate diagnoses and personalized treatment plans. The use of scalable cloud computing platforms ensures that the system can handle the ever-increasing volume of genomic data, making it a sustainable solution for genomic research. Overall, this study demonstrates the potential of AI-based methods to transform the field of genomic variant analysis, paving the way for more precise and efficient applications in clinical genomics and precision medicine (Adebayo, 2023).
Statement of the Problem
Despite the proliferation of genomic data, the accurate analysis of genomic variants remains a significant challenge. At Adamawa State University, Mubi, conventional variant calling and annotation tools often fall short in terms of accuracy and efficiency, particularly when processing large-scale datasets (Bello, 2023). These traditional methods are prone to errors, such as high false-positive rates and difficulty in distinguishing rare pathogenic variants from benign polymorphisms. Moreover, the integration of diverse data sources for variant interpretation is fragmented, leading to inconsistencies in clinical decision-making. The absence of a unified AI-based approach exacerbates these issues, resulting in delayed diagnoses and suboptimal patient care. This study seeks to address these challenges by implementing and evaluating AI-based methods that can automate and enhance the detection and classification of genomic variants. By employing state-of-the-art deep learning algorithms and integrating multiple genomic databases, the proposed approach aims to provide a more accurate and efficient pipeline for variant analysis. Overcoming these limitations is critical for improving the predictive power of genomic studies and facilitating the transition to precision medicine. The expected outcome is a robust system that not only streamlines variant analysis but also offers comprehensive functional annotations to guide clinical interventions (Okafor, 2024).
Objectives of the Study
To implement AI-based models for the detection and classification of genomic variants.
To integrate multi-source genomic data for comprehensive variant annotation.
To evaluate the accuracy and efficiency of the AI-based approach compared to traditional methods.
Research Questions
How do AI-based methods improve the accuracy of genomic variant detection?
What is the impact of integrating multiple genomic databases on variant classification?
How does the AI-based approach compare to traditional methods in terms of processing speed and error rate?
Significance of the Study
This study is significant as it explores AI-based approaches to revolutionize genomic variant analysis. By enhancing detection accuracy and reducing error rates, the research supports more precise clinical diagnoses and personalized treatment strategies, ultimately contributing to advancements in precision medicine (Ibrahim, 2023).
Scope and Limitations of the Study
The study is limited to the evaluation of AI-based genomic variant analysis at Adamawa State University, Mubi, focusing solely on genomic sequencing data. It does not extend to in vitro functional assays or clinical trials.
Definitions of Terms
Genomic Variant: A variation in the DNA sequence among individuals, including SNPs and indels.
Deep Learning: A subset of machine learning involving neural networks with multiple layers that automatically extract features from data.
Variant Calling: The process of identifying genetic variations from sequencing data.
Background of the Study
Environmental accounting involves the process of recording, reporting, and anal...
ABSTRACT
This study was carried out to examine the impact of micro credit programmes on entrepreneurshi...
Background of the Study
The rise of digital communication has ushered in significant linguistic changes, particularly in S...
Background of the Study
Text normalization is a critical preprocessing step in natural language processin...
Background of the Study
Accessibility in education is crucial to ensure that all students, including those with disabilities, have an equal...
Background of the Study
Customer satisfaction is a critical factor in the banking sector, influencing customer retention, brand loyalty,...
Background of the Study
Market associations, which are organized groups of traders, are vital in the ec...
ABSTRACT
The manual approach used in the regulation of the school activities by the management board is very tedious and stressful. ...
Background of the Study
Global temperature rise, a hallmark of climate change, is increasingly affecting...
ABSTRACT
This study was carried out to assess of human activities on global warming using federal...